bunazosin has been researched along with Kidney Diseases in 1 studies
bunazosin: structure
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There were, however, neither prolongation of apparent elimination half-life (t1/2), nor increase in Cmax, nor area under the plasma concentration-time curve (AUC0-24) after consecutive dosing in both groups." | 2.67 | Pharmacokinetics and pharmacodynamics of the alpha 1-adrenergic antagonist bunazosin retard in hypertensives. ( Gotoh, E; Ishii, M; Minamisawa, K; Minamisawa, M; Shionoiri, H; Sugimoto, K; Takasaki, I; Takizawa, T; Ueda, S, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shionoiri, H | 1 |
| Minamisawa, M | 1 |
| Ueda, S | 1 |
| Minamisawa, K | 1 |
| Takizawa, T | 1 |
| Takasaki, I | 1 |
| Sugimoto, K | 1 |
| Gotoh, E | 1 |
| Ishii, M | 1 |
1 trial available for bunazosin and Kidney Diseases
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of the alpha 1-adrenergic antagonist bunazosin retard in hypertensives.
Topics: Adrenergic alpha-1 Receptor Antagonists; Blood Pressure; Delayed-Action Preparations; Female; Half-L | 1994 |